Os investidores ajustam as participações na Abbott e na AbbVie, ambas reportando fortes ganhos e dividendos. Investors adjust stakes in Abbott and AbbVie, both of which reported strong earnings and dividends.

Vários investidores institucionais ajustaram recentemente suas participações nas empresas de saúde Abbott Laboratories e AbbVie Inc. A Harel Insurance Investments comprou 1.458 ações da Abbott, elevando seu total para 2.451 ações, avaliadas em US$ 325.000. Several institutional investors have recently adjusted their stakes in healthcare companies Abbott Laboratories and AbbVie Inc. Harel Insurance Investments bought 1,458 shares of Abbott, bringing its total to 2,451 shares, valued at $325,000. A Novare Capital Management reduziu suas participações na Abbott em 1,9%, enquanto a Concurrent Investment Advisors aumentou suas participações na AbbVie em 26,5%, agora detendo 93.773 ações. Novare Capital Management reduced its holdings in Abbott by 1.9%, while Concurrent Investment Advisors increased its holdings in AbbVie by 26.5%, now owning 93,773 shares. Ambas as empresas relataram ganhos fortes, com a Abbott superando as expectativas e declarando um dividendo trimestral de US $ 0,59. Both companies reported strong earnings, with Abbott exceeding expectations and declaring a $0.59 quarterly dividend. A AbbVie também superou as estimativas de ganhos e anunciou um dividendo trimestral de US $ 1,64. AbbVie also surpassed earnings estimates and announced a $1.64 quarterly dividend.